Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Classification of Epithelial Tissues: Glandular Epithelium01:20

Classification of Epithelial Tissues: Glandular Epithelium

8.8K
The glandular epithelium is made of one or more epithelial cells modified to synthesize and secrete chemical substances. Glandular epithelia can be classified based on cell number. Unicellular glands have individual secretory cells scattered across the epithelial monolayer. In contrast, multicellular glands consist of a hollow tubular duct attached to the cluster of secretory cells located in the deep pockets.
Multicellular glands are formed during early development when epithelial budding...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PATZ1 Immunohistochemistry Aids in the Diagnosis of PATZ1-Rearranged Sarcomas.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancer.

Cancer cell·2026
Same author

Localization of mast cells in human brain tissue: Implications for neuropsychiatric symptoms in COVID-19.

Journal of neuropathology and experimental neurology·2026
Same author

Consensus recommendations for malignant histiocytic neoplasms (histiocytic, Langerhans, and interdigitating dendritic cell sarcomas).

Blood·2026
Same author

Defining Prognostic Markers and Clinical Outcomes in Epithelioid Malignant Peripheral Nerve Sheath Tumor.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Histologic Distinction Between Clear Cell Sarcoma and Melanoma Using Supervised and Deep Learning.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2026

Related Experiment Video

Updated: Jul 15, 2025

Two-step Approach to Explore Early- and Late-stages of Organ Formation in the Avian Model: The Thymus and Parathyroid Glands Organogenesis Paradigm
13:43

Two-step Approach to Explore Early- and Late-stages of Organ Formation in the Avian Model: The Thymus and Parathyroid Glands Organogenesis Paradigm

Published on: June 17, 2018

7.5K

PAX1 expression in thymic epithelial neoplasms and morphologic mimics.

Paige H Parrack1, Jason L Hornick1, Lynette M Sholl1

  • 1Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA, 02115.

Human Pathology
|September 30, 2023
PubMed
Summary

PAX1 immunohistochemistry shows moderate-to-high sensitivity for thymic epithelial neoplasms. While not replacing PAX8, PAX1 may aid in diagnosing thymic tumors, despite staining variability and fixation challenges.

Keywords:
PAX1PAX8Thymic carcinomaThymomaThymus

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.0K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.6K

Related Experiment Videos

Last Updated: Jul 15, 2025

Two-step Approach to Explore Early- and Late-stages of Organ Formation in the Avian Model: The Thymus and Parathyroid Glands Organogenesis Paradigm
13:43

Two-step Approach to Explore Early- and Late-stages of Organ Formation in the Avian Model: The Thymus and Parathyroid Glands Organogenesis Paradigm

Published on: June 17, 2018

7.5K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.0K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.6K

Area of Science:

  • Oncology
  • Pathology
  • Immunohistochemistry

Background:

  • Thymic epithelial neoplasms present diagnostic challenges due to morphological diversity.
  • Current immunohistochemistry (IHC) markers lack complete sensitivity and specificity for thymic epithelium.
  • PAX8 is commonly used but not entirely specific; PAX1 plays a role in thymic development.

Purpose of the Study:

  • To evaluate the utility of PAX1 immunohistochemistry (IHC) in distinguishing thymic epithelial neoplasms from morphologic mimics.
  • To assess the sensitivity and specificity of PAX1 IHC in various thymic tumors and non-thymic mimics.

Main Methods:

  • Whole slide tissue sections of 74 thymoma cases and various morphologic mimics were analyzed using PAX1 IHC.
  • Staining intensity and patterns were evaluated across different thymic neoplasm subtypes and non-thymic tumors.
  • Sensitivity and specificity were calculated using an H-score positive threshold of 75.

Main Results:

  • PAX1 antibody stained all 74 thymomas but showed variable intensity.
  • Sensitivity was lower in thymic carcinomas (47%) and neuroendocrine tumors (56%) compared to thymomas (92%).
  • Weak staining was observed in a subset of mimics; specificity was 100% with the defined threshold. Variable formalin fixation impacted antigenicity.

Conclusions:

  • PAX1 IHC demonstrates moderate-to-high sensitivity for thymic epithelial neoplasms.
  • Staining variability and fixation effects can complicate consistent interpretation.
  • PAX1 may serve as a valuable adjunct to existing IHC panels for thymic primary tumors, rather than a standalone marker.